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ABSTRACT
The healthy effects of plant polyphenols, some of which characterize the so-
called Mediterranean diet, have been shown to arise from epigenetic and biological 
modifications resulting, among others, in autophagy stimulation. Our previous work 
highlighted the beneficial effects of oleuropein aglycone (OLE), the main polyphenol 
found in the extra virgin olive oil, against neurodegeneration both in cultured cells 
and in model organisms, focusing, in particular, autophagy activation. In this study 
we investigated more in depth the molecular and cellular mechanisms of autophagy 
induction by OLE using cultured neuroblastoma cells and an OLE-fed mouse model of 
amylod beta (Aβ) deposition. We found that OLE triggers autophagy in cultured cells 
through the Ca2+-CAMKKβ–AMPK axis. In particular, in these cells OLE induces a rapid 
release of Ca2+ from the SR stores which, in turn, activates CAMKKβ, with subsequent 
phosphorylation and activation of AMPK. The link between AMPK activation and mTOR 
inhibition was shown in the OLE-fed animal model in which we found that decreased 
phospho-mTOR immunoreactivity and phosphorylated mTOR substrate p70 S6K levels 
match enhanced phospho-AMPK levels, supporting the idea that autophagy activation 
by OLE proceeds through mTOR inhibition. Our results agree with those reported 
for other plant polyphenols, suggesting a shared molecular mechanism underlying 
the healthy effects of these substances against ageing, neurodegeneration, cancer, 
diabetes and other diseases implying autophagy dysfunction. 
INTRODUCTION
An increasing body of evidence points to a 
number of natural polyphenols as protective tools 
against cell sufferance and death in a wide number of 
human pathologies spanning from neurodegenerative to 
cardiovascular diseases, cancer and diabetes, including 
ageing. These molecules include compounds such as 
resveratrol, epigallocatechin-3-gallate (EGCG), curcumin, 
morin, quercetin and oleuropein aglycone (OLE) found in 
a number of foods of plant origin and believed to be at the 
basis of the claimed beneficial properties of these foods 
[1]. The wide interest raised around these molecules as 
potential tools to combat such a wide range of diseases 
or, at least, to reduce the severity of their symptoms 
and/or age of occurrence has prompted many groups 
to investigate various aspects of their physiological 
actions both at the cellular and molecular level and in 
animal models of a number of pathological conditions, 
particularly cancer, inflammatory, cardiovascular and 
neurodegenerative diseases [2,3]. A number of shared 
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properties of these compounds includes their anti-oxidant, 
anti-inflammatory and anti-amyloidogenic power, and 
many benefits following their intake have been rationalised 
in the light of these recognised effects. However, more 
recently, other properties of these compounds arising from 
their interaction with cellular systems and potentially 
explaining their beneficial effects have been described. 
One of these is their ability to raise, in a number of 
different cell types, the autophagic response involved in 
protection against neurodegeneration, liver and vascular 
diseases [4-6]. 
Autophagy is a key process involved in cell 
homeostasis of proteins (proteostasis), lipids and 
organelles and contributes to clear materials of 
endogenous or exogenous origin. Together with the 
ubiquitin-proteasome system, autophagy participates to 
cellular proteostasis as one of the two main pathways of 
intracellular proteolysis, even though the former applies 
to the short-lived intracellular proteins, whereas the latter 
concerns proteins with longer half-lives. Autophagy 
encompasses the different routes used by cells to deliver 
cytoplasmic substrates to lysosomes through the formation 
of autophagosomes that subsequently fuse with lysosomes 
to form autophagolysosomes [7]. Usually, autophagy is 
triggered upon starvation, however it can be activated 
also by the presence of deposited materials as well as to 
degrade aged cellular organelles, principally mitochondria 
(mitophagy). Autophagy efficiency declines with age, with 
consequent accumulation of harmful protein aggregates 
and damaged mitochondria, which leads to increased ROS 
production [8]. The resulting increased cell stress favors 
inflammation and cell death [9].
Canonical autophagy, also known as 
macroautophagy, is a highly conserved process shared by 
all organisms which can be triggered in different ways and 
requires the participation of over 20 ATG proteins in yeast. 
The most straightforward path requires the inhibition of 
a cytoplasmic kinase receptor, the mammalian target 
of rapamycin (mTOR). mTOR forms two functionally 
distinct protein-mTOR complexes (mTORC1 and 
mTORC2) that are at the centre of an intricate, and 
still incompletely described, signalling pathway that is 
activated in response to a number of stress stimuli [10]. 
At the onset of the process, these complexes control the 
activation of the autophagy-initiating kinase (ULK1). 
mTORC1 inactivation in response to nutrient deprivation 
results in the activation of the ULK1 complex with 
ensuing induction of autophagy [7]. Autophagy senses, 
among others, the energy status of the cell and therefore 
responds to any cytosolic alteration of the AMP/ATP ratio 
which, in turn, signals to a number of kinases including 
liver kinase B1 (LKB1) and adenosine monophosphate-
dependent protein kinase (AMPK). AMPK is activated 
upon phosphorylation by a number of upstream kinases 
including LKB1 and calmodulin-dependent kinase 
kinase β (CaMKKβ ), the latter in response to free Ca2+ 
increase, following the stimulation of the cAMP-inositol 
1,4,5-triphosphate (IP3)/Akt and calpain-G-stimulatory 
protein α (Gsα) pathways [11]. In turn, activated AMPK 
promotes autophagy by phosphorylation and activation of 
ULK1 [12] and inhibition of mTORC1 .
Autophagy abnormalities may contribute to many 
different pathophysiological conditions [13]; thus 
autophagy is increasingly considered as a promising 
target to treat a number of pathologies, particularly those 
associated with neurodegeneration [10] as well as ageing 
[14]. Actually, increased mTOR activity has been reported 
in cellular and animal models of Alzheimer’s disease (AD) 
[15] as well as in Huntington animal models and disease 
[16, 17]; inducing autophagy can also be beneficial in 
amyotrophic lateral sclerosis [18]. 
Plant polyphenols are able to regulate autophagy 
in several ways. In particular, some polyphenols, such as 
resveratrol and EGCG, appear to promote the autophagic 
pathway by increasing cytosolic Ca2+ levels and activating 
AMPK by the CaMKKβ [4-6, 8]. Our previous data have 
highlighted the beneficial effects of OLE against protein/
peptide aggregation in vitro [19, 20]. More importantly, 
our findings showed that TgCRND8 mice, a strain widely 
used as a model of amylod beta (Aβ) peptide deposition, 
fed with OLE displayed strongly improved performance in 
behavioural and cognitive tests; this effect was paralleled 
by reduced plaque load and plaque disassembly, in the 
affected brain areas, reduced inflammatory response, 
recovered dysfunctions of transgene-induced long-term 
potentiation (LTP) in the CA1 hippocampal area and 
reduced production of the pyro-Glu-Aβ 3-42 peptide, 
a recognised amyloid nucleator. These effects were, at 
least in part, accompanied and explained by epigenetic 
modifications [21] and, most remarkably, by a strong 
activation of autophagy [22, 23]. Autophagy stimulation 
by OLE agrees with the data previously reported for 
other plant polyphenols [24, 25], however, at variance 
with those, our data did not highlight any mechanistic 
explanation. To fill this gap and to expand the knowledge 
in the field not only in cultured cells but also in model 
animals, we investigated the molecular and cellular 
mechanisms of autophagy induction by OLE both in vitro 
in neuroblastoma SH-SY5Y cells and in vivo in TgCRND8 
mice. 
RESULTS
OLE induces a biphasic increase in AMPK 
phosphorylation at its regulatory Thr172
We previously showed that diet supplementation 
with OLE strongly ameliorates AD-associated symptoms 
in TgCRND8 mice, a model of Aβ deposition, in several 
ways, including induction of autophagy [21-23]; a similar 
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behaviour was also shown in OLE-treated murine N2a 
neuroblastoma cells [23]. We therefore sought to elucidate 
the molecular mechanism underlying autophagy activation 
by investigating at which level OLE interfered with the 
autophagy cascade in SH-SY5Y human neuroblastoma 
cells. Previous data suggested that other polyphenols, such 
as resveratrol and EGCG, promote the autophagy flux 
by increasing the cytosolic Ca2+ levels with subsequent 
activation of AMPK by CaMKKβ [4-6]. Therefore, our 
primary aim was to assess if the molecular mechanism 
of autophagy induction in OLE-exposed SH-SY5Y cells 
was similar to that previously reported for other natural 
polyphenols. To do this, we initially exposed the cells to 50 
μM OLE for 24 h, the conditions we previously reported 
to trigger autophagy in N2a cells [23] and then checked 
the cells for both Beclin-1 level (whose increase is an 
early marker of autophagy) and AMPK phosphorylation. 
However, no variation in the phosphorylation of the 
AMPK catalytic subunit at the regulatory Thr172 residue 
was observed at these conditions in spite of a significant 
increase in Beclin-1 expression (Figure 1A). 
This negative result prompted us to explore whether 
an hypothetical OLE-mediated AMPK activation was an 
early event that disappeared after 24 h of cell treatment. 
In order to reduce the time frame of our treatments, at 
first we checked if autophagy was induced in SH-SY5Y 
cells after only 4 h of cell treatment with 50 μM OLE. At 
these conditions, autophagic vacuoles staining was evident 
suggesting that autophagy was indeed triggered even at 
this short time of treatment (Figure 1B). Accordingly, we 
analysed the phosphorylation level of AMPK within this 
time interval. We observed a biphasic significant increase 
of AMPK phosphorylation with respect to vehicle-treated 
cells after both 10’ and 4 h of OLE treatment (Figure 1C), 
supporting a close relation between autophagy induction 
and AMPK phosphorylation following cell exposure to 
OLE for reduced time periods.
OLE induces a biphasic increase of the 
intracellular Ca2+levels
It is well known that AMPK phosphorylation 
can result from the activation of the Ca2+-dependent 
Figure 1: OLE induces autophagy and a biphasic increase in AMPK phosphorylation during short treatments. SH-
SY5Y cells were treated with OLE for 24 h, then A. (Upper panel) beclin-1 expression and AMPK phosphorylation were analysed by 
immunoblotting. β-actin was used to normalize beclin-1 expression. (Lower panel) Quantitative data. B. Treatment with OLE for 4 h 
determined an increase of autophagic vacuoles staining, detected by the Cyto ID-green Dye. Scale bar: 25 µm. C. (Upper panel) A biphasic 
increase in AMPK phosphorylation, detected by immunoblotting analysis, was evident in cells treated with OLE for increasing time 
periods. (Lower panel). Quantitative data. All data are Mean ± S.E.M. The asterisk (*) indicate a significant statistical difference with 
respect to vehicle-treated cells. *P < 0.05 **P < 0.01 *** P < 0.001. n = 3.
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Ser-Thr kinase CaMKKβ, a mechanism that accounts 
for autophagy induction by resveratrol and EGCG [4-
6]. Therefore, we sought to explore whether, in our 
conditions, CaMKKβ was indeed involved even in the 
relation between cell treatment with OLE and the ensuing 
AMPK phosphorylation. To this purpose, we investigated 
the trend of the increase of intracellular free Ca2+ in OLE-
treated cells to check whether it was associated to the 
biphasic character of AMPK phosphorylation. By using the 
fluorescent probe Fluo3-AM we found an early increase 
of the cytosolic Ca2+ after 5’-10’ of OLE treatment, with 
a subsequent decrease at 30’ (yet significantly above the 
basal level) followed by a late increase after 1- 2 h, while 
after 5 h the Ca2+ level was no more significantly different 
from the basal level (Figure 2). These data suggested a 
temporal correlation between cytosolic Ca2+ increase and 
AMPK phosphorylation in OLE-treated cells. 
Then, we focused at the early peak of Ca2+ increase 
and checked whether, in OLE-treated cells, the increased 
Ca2+ came from the extracellular medium or it was released 
from the intracellular stores. To do this, the cells, before 
treatment with OLE for 10 min, were incubated for 30 
min with the cell-impermeant Ca2+ chelator EGTA or with 
CPA, an inhibitor of the endoplasmic reticulum (ER) Ca2+ 
pump which causes depletion of the ER stores. At these 
conditions, we found that only CPA abolished the OLE-
induced Ca2+ increase, whereas cell treatment with EGTA 
did not induce any significant effect (Figure 3), suggesting 
that the free Ca2+ increase in OLE-treated cells resulted 
from ER release. We concluded that, in OLE-treated cells, 
AMPK phosphorylation paralleled Ca2+ increase coming 
from the ER, which suggested a pivotal role of the Ca2+-
activated CaMKKβ.
Figure 2: OLE induces a biphasic increase in intracellular Ca2+ levels during short treatments. SH-SY5Y cells were treated 
with 50 µM OLE for different time periods. At the end of each treatment, the cells were washed with PBS and incubated for 30 min at 37 
°C with 10 µM Fluo-3AM as probe for detection of cytosolic calcium levels. Asterisks (*) indicate significant statistical differences with 
respect to time zero. *P < 0.05, **P < .0.01, *** P < 0.001. Scale bar: 25 µm n = 3.
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Figure 3: OLE determines the release of Ca2+ from the intracellular stores after 10’ of cell stimulation. SH-SY5Y cells 
were pre-treated with CPA or EGTA before exposure to OLE for 10’. Cytosolic calcium levels were detected using the Fluo-3AM probe and 
the fluorescent signal was superimposed to phase-contrast images of the cells. Scale bar: 25 µm. The asterisks indicate significant statistical 
differences respect to vehicle treated cells, the circles indicate statistically significant differences with respect to OLE-treated cells. ***P 
< 0.001, °°° P < 0.001. n = 3.
Figure 4: OLE-induced AMPK phosphorylation depends on CaMKKβ signalling. SH-SY5Y cells were pre-treated with 
the CaMKKβ inhibitor STO-609 before adding OLE for 10’ or 4 h. (Left) Cellular extracts were analysed by immunoblotting. (Right) 
Quantitative data. The asterisks indicate a statistically significant difference respect to vehicle treated cells, the circles indicate statistically 
significant differences with respect to OLE-treated/STO-609-untreated cells. *P < 0.05, ** P < 0.01, ° P < 0.05, °°P < 0.01 n = 3.
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CaMKKβ activation is needed for OLE-
autophagy induction 
To investigate whether CaMKKβ activation was 
indeed involved in the OLE-triggered AMPK activation, 
the cells were incubated with STO-609, a CAMKKβ 
inhibitor, prior to treatment with OLE for 10 min or 4 
h. The subsequent western blotting analysis showed 
that, when CaMKKβ was inhibited, the level of AMPK 
phosphorylation was significantly lower than that 
measured both in the presence of OLE and in the absence 
of STO-609 and did not differed significantly from that 
found in OLE-untreated controls (Figure 4). 
The above reported data suggest that cell treatment 
with OLE for 10 min induces a rise of free Ca2+ coming 
from the ER stores, which results in CaMKKβ activation 
and subsequent AMPK phosphorylation. Therefore, we 
investigated whether such a short-time treatment was 
sufficient to trigger autophagy and, if so, whether Ca2+ 
increase and CaMKKβ activation did play a role. So, the 
cells were pre-treated with EGTA, CPA or STO-609 for 
30 min and then incubated with OLE for 10 min. Then the 
cells were washed and incubated for 5 h in complete fresh 
medium after which autophagy induction was measured. 
At these conditions, the cells displayed a significant 
increase in autophagic vacuoles staining (Figure 5A), 
suggesting that autophagy activation resulting from Ca2+ 
release from the ER in OLE-treated cells is an early 
event, and that longer times of incubation with OLE are 
not needed for autophagy induction. In fact, the latter 
was absent in cells pre-treated with CPA, confirming 
that Ca2+ release from the ER induced by a short acute 
(10 min) stimulus by OLE is essential for autophagy 
activation. We also confirmed the involvement of the 
Ca2+-activated CaMKKβ in such signalling cascade, since 
cell pre-treatment with STO-609 abolished OLE-induced 
increase of autophagic vacuoles staining. On the contrary, 
cell pre-treatment with EGTA did not inhibit autophagy, 
suggesting that the extracellular Ca2+ plays a minor role in 
the signalling cascade, at least in cells treated with OLE 
for short time periods. 
The above findings are supported by the analysis 
of the time course of Beclin-1 expression that showed a 
slight, yet significant, transitory increase during the first 
minutes of OLE treatment, reaching a peak at 30 min 
(Figure 5B). Considering the short time of incubation 
with OLE, it is unlikely that such an increase stems from 
raised synthesis; rather it could arise from the Beclin-1 
fraction complexed with Bcl-2/Bcl-xL in the cytoplasm. 
Actually, release of Beclin-1 from its complex with Bcl-2 
is critical for inducing autophagy as free Beclin-1- VPS34 
interaction is needed to initiate autophagosome formation 
Figure 5: Short time cell treatment with OLE efficiently triggers the autophagic cascade. SH-SY5Y cells were pre-treated 
with STO-609, CPA or EGTA before treatment with OLE for 10 min’.Then the cells were washed and incubated for 5 h in complete fresh 
medium. A. (Upper panel) Autophagy induction was measured by staining autophagic vacuoles with the Cyto ID green Dye. Scale bar: 30 
µm. (Lower panel) Quantitative data. B. (Upper panel) Time course of beclin-1 expression during -short time treatments with OLE. β-actin 
was used to normalize beclin-1 expression. (Lower panel) Quantitative data. The asterisks (*) indicate statistically significant differences 
with respect to vehicle treated cells, the circles (°) indicate statistically significant differences with respect to OLE-treated cells. **P < 0.01, 
°°° P < 0.001 n = 3.
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[26]. A more consistent later increase in Beclin-1 
expression had been already observed in cells exposed for 
24 h to OLE (Figure 1). We conclude that cell exposure to 
OLE for a time as short as 10 min is sufficient to increase 
free cytosolic Ca2+ coming from the ER which, in turn, 
activates CaMKKβ with ensuing induction of AMPK 
phosphorylation and activation of the autophagic flux.
AMPK activation is needed for autophagy 
induction by OLE 
Finally, we evaluated the correlation between 
AMPK activation and autophagy induction by OLE using 
compound C (CC), the only known AMPK inhibitor. 
We expected no autophagy induction in the presence 
of CC; however, we observed that autophagy was still 
Figure 6: The AMPK inhibitor Compound C (CC) induces autophagy per se in SH-SY5Y and reduces OLE-induced 
autophagy. The SH-SY5Y cells were treated with OLE in the presence or in the absence of CC. (Upper panel) Autophagy induction was 
measured by staining autophagic vacuoles with the Cyto ID green Dye. Scale bar: 25 µm. (Lower panel) Quantitative data. The asterisks 
(*) indicate a statistically significant difference respect to vehicle-treated cells, the circles (°) indicate a statistically significant difference 
with respect to OLE treated cells. **P < 0.01, ***P < 0.001 ,°° P < 0.01. n = 3.
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activated, though to a reduced extent, at these conditions. 
To explain this effect, we checked whether CC induced 
basic autophagy in control cells; actually, we observed 
that CC is an autophagy activator per se (independently 
of any effect on AMPK activity) in this cell line (Figure 
6), as it was previously reported for other cancer cells [27, 
28]. Nevertheless, CC, even though did not completely 
abolish, significantly reduced OLE-autophagy activation, 
suggesting a strong prevalence of the pathway proceeding 
through AMPK even in this case. To confirm this 
hypothesis, we used a different, CC-insensitive, cell line 
chosen after testing a panel of different lines. We found 
an useful model in the rat pancreatic insulinoma RIN-5F 
cells, in which CC does not trigger autophagy. In these 
cells, OLE-treatment activated autophagy similarly 
to what observed in SH-SY5Y cells but this effect was 
significantly counteracted by cell pretreatment with CC, 
as shown both by autophagic vacuoles staining (Figure 
7A) and by western blot analysis of LC-3 II (Figure 7B). 
These results fully confirmed, in a different cell line, that 
the activation of AMPK signaling plays a paramount role 
in OLE-induced autophagy, supporting the hypothesis that 
autophagy activation occurs mainly, if not exclusively, 
through the path OLE - Ca2+ increase - CaMKKβ 
activation - AMPK phosphorylation. 
OLE inhibits mTOR via activation of AMPK in 
the cortex of TgCRND8 mice
To confirm and extend in tissue the proposed 
mechanism of autophagy activation by OLE in cultured 
cells, we used TgCRND8 mice, an in vivo model, of 
Aβ deposition which mimics some features of AD. We 
previously reported that OLE supplementation for 8 
weeks to daily food of TgCRND8 mice induces an intense 
autophagic response and lysosomal activity in the cortex 
of animals of different ages (23). On the basis of these 
Figure 7: CC blocks autophagy induction by OLE in RIN-5F cells. RIN-5F cells were pre-treated with CC before exposure 
to OLE for 4 h A. (Upper panel) Autophagic vacuole staining was detected by the Cyto ID-green Dye. Scale bar: 25 µm. (Lower panel) 
Quantitative data. B. (Upper panel) Cell extracts were analysed by immunoblotting with anti-LC3. β-actin was used to assess equal protein 
loading. (Lower panel) Quantitative data. The asterisks (*) indicate a statistically significant difference with respect to vehicle-treated cells. 
The circles (°) indicate a statistically significant difference with respect to OLE-treated cells. *** P < 0.001, °°°P < 0.001 n = 3.
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data, we explored the involvement of mTOR and AMPK 
in OLE-triggered autophagy in the cortical tissue of 6/12 
month-old TgCRND8 mice fed with OLE. As expected, 
in the cortex of control, OLE-untreated, TgCRND8 mice 
we found enhanced phospho-mTOR immunoreactivity 
(Figure 8A) and increased levels of the phosphorylated 
mTOR substrate p70 S6K (Figure 8B); however, these 
modifications were markedly reduced in the cortex of 
OLE-fed TgCRND8 mice, where no significant differences 
with controls were detected. These data further support 
the idea that autophagy activation by OLE proceeds 
through mTOR inhibition. Next, we assessed whether 
the latter matched AMPK activation; we found enhanced 
levels of phospho-AMPK, and hence AMPK activation, 
in the cortex of OLE-fed TgCRND8 mice as compared 
to untreated animals (Figure 6C). Altogether, these data 
indicate that in the cortex of OLE-fed TgCRND8 mice 
the activation of autophagy likely occurs following AMPK 
activation, and that the latter matches mTOR inhibition. 
No age-related differences in both mTOR and AMPK 
data were detected in 6 month-old and in 12 month-old 
mice, thus the two age groups were pooled and reported 
as 6/12 months. Taken together, these results confirm those 
obtained with cultured cells and match those previously 
reported with a different neuroblastoma cell line [23], 
confirming that comparable molecular mechanisms of 
OLE-autophagy activation are present both in cultured 
cells and in tissue.
Figure 8: OLE restores to control levels the expression of phospho-mTOR, phospho-p70S6K and phospho-AMPK 
in the cortex of 6-12-month-old TgCRND8 mice. A. Representative photomicrographs of phospho-mTOR immunoreactivity in 
the cortex of 12-month-old mice; note, the less intense phospho-mTOR staining in OLE-fed Tg mice, in untreated and OLE-fed wt mice 
compared with untreated Tg mice. Scale bar: 50 µm. B., C. (Lower panel) Analysis of phospho-p70S6K and phospho-AMPK, detected by 
immunoblotting, respectively. (Upper panel) Quantitative data. The asterisks (*) indicate a statistically significant difference with respect 
to untreated Tg mice. *P < 0.05, **P < 0.01 (n = 5-6 mice/group) .
Oncotarget35353www.impactjournals.com/oncotarget
DISCUSSION
A growing body of research has shown that 
polyphenols of plant origin have beneficial properties 
against ageing and a number of pathological 
conditions spanning from cancer, cardiovascular and 
neurodegenerative diseases, age-related metabolic 
deterioration and diseases including type 2 diabetes and 
the metabolic syndrome and neurodegenerative diseases. 
The presence of plant polyphenols at substantial levels 
in a number of foods that characterize the Mediterranean 
and the Asian diets, has been recognized as a leading 
explanation of the benefits for health of these alimentary 
regimens [1, 29]. Plant polyphenols possess a number of 
properties that can contribute to explain their effects on 
health, the most recognized being their antioxidant, anti-
inflammatory and anti-aggregation power. However, these 
properties, although of importance, cannot explain by 
themselves the remarkable effects of these molecules that 
appear not generic but, rather, very specific, even though 
shared. In fact, they are able to impact on cell viability 
by interfering with a number of basic processes including 
transcriptional regulation through epigenetic effects and 
autophagy [8, 21, 23].
Recent research has sought to decipher the 
polyphenol-cell biology relations by investigating some 
of these substances that are present in foods of large use 
including red wine, green tea, extra virgin olive oil and 
the turmeric. The data reported in recent years have shown 
that specific polyphenols such as resveratrol, EGCG and 
curcumin are able to elicit the autophagic response thus 
improving such housekeeping tool that results in increased 
cell longevity and favors the clearance of misfolded/
aggregated peptides and proteins in several human 
amyloid diseases [8]. 
It is widely known that autophagy activation can 
result from different pathways including the phospho-
inositol-(IP3) signalling, the Ca2+-calpains-Gsα pathways 
[30], in addition to the Ca2+ -CaMKKβ (LKB1)-AMPK-
mTOR pathway. The molecular basis of autophagy 
activation by a number of polyphenols have been 
investigated; they include the pivotal role of AMPK, a 
heterotrimeric Ser/Thr kinase, that is activated by several 
upstream kinases, including LKB1 and CaMKKβ, and, 
in turn, negatively controls mTOR, a potent inhibitor 
of autophagy [31-33]. CaMKKβ is activated by free 
Ca2+, whose cytosolic levels appear important to initiate 
the autophagy flux. Ca2+ increase seems to be the main 
upstream biochemical modification induced by several 
polyphenols as well as a primary cause that eventually 
leads to the activation of autophagy. However, at present, 
it cannot be concluded that this is a basic effect shared by 
plant polyphenols known to be protective against ageing 
and disease, nor whether different polyphenols trigger 
different autophagy pathways. 
Recently, we have shown that, in the TgCRND8 
mice, OLE administration with the food results in reduction 
of Aβ peptide production and neuroinflammation; more 
remarkably, it induces other significant effects, restoring 
LTP, reducing the number and compactness of the plaques, 
activating the microglia and, most importantly, promoting 
an intense autophagic response [21, 23]. However, nothing 
was known at the molecular level about the mechanism 
of the latter effect. In this study we tried to fill the gap 
by investigating some molecular mechanisms underlying 
autophagy activation by OLE both in vitro in neuronal 
cells and in vivo in TgCRND8 mice. In the latter, the 
activation of AMPK which, in turn, negatively modulates 
mTOR, could underlie the previously reported OLE-
induced intense autophagic and lysosomal response in the 
brain cortex of OLE-fed mice [23]. 
Here, we found that OLE induces autophagy 
in cultured neuroblastoma cells by a mechanism 
substantially in accordance with those previously 
reported for other polyphenols, confirming that in cells 
treated with polyphenols the Ca2+/CaMKKβ/AMPK/
mTOR axis is actually at work. We found that the Ca2+ 
rise in OLE-treated cells was the result of Ca2+ exit from 
the intracellular stores rather than of its entry from the 
external medium. This implies that OLE penetrates inside 
the cell though the plasmamembrane without damaging it. 
We did not checked the presence of OLE inside the cells, 
however, this would not be surprising, considering that 
the molecule is hydrophobic. Moreover, such a possibility 
is supported by a recent report where it has clearly been 
shown that compounds from olive leaves, including OLE, 
are found inside treated cells in a breast-cancer cell line 
[34]. We have previously reported that a time-dependent 
decrease of phosphorylation of the mTOR substrate p70 
S6K occurs in N2a cells, a different neuroblastoma cell 
line, treated with OLE at the same concentration used 
in this study [23], confirming that autophagy activation 
by OLE proceeds through AMPK activation and mTOR 
inhibition. Of interest, in the same study, AMPK activation 
was evident at 3-6 h of OLE treatment, a time similar to 
that at which, in this study, we found the highest peak 
of AMPK phosphorylation. Taken together, these data 
support the hypothesis that autophagy activation by OLE 
proceeds via the AMPK/mTOR signalling pathway. That 
a panel of coherent, yet not completely matching, results 
were found with different cultured cells does not weakens 
the take-home message of this study; rather it strengthens 
it, confirming that similar molecular mechanisms underlie 
OLE-induced activation of autophagy in different cell 
types as well as in mouse tissue.
The above considerations open intriguing 
consequences. For example, it has been repeatedly 
reported that some polyphenols, including OLE, are 
able to induce epigenetic modifications, in terms of 
histone acetylation and DNA methylation, particularly 
in cancer cells [35] and that, in the brain of OLE-
fed TgCRND8 mice, modified expression levels of 
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key proteins including glutaminyl cyclase, Beclin-1, 
LC-3 II and histone deacetylase-2 were found [21]. In 
such a scenario the transcriptor factor EB (TFEB), a 
transcriptional regulator of lysosomal biogenesis that 
controls the expression of central autophagy genes [4-6], 
could perform an important role; in fact, it appears to be 
inhibited upon phosphorylation by mTORC and activated 
upon dephosphorylation by calcineurin, a phosphatase 
that has recently been shown to be activated by lysosomal 
Ca2+ [36]. Hence, autophagy appears to be regulated by 
Ca2+ signals coming from different cell stores that affect 
independently but, possibly, synergistically, the autophagic 
flux. In this context, the Ca2+/CaMKKβ/AMPK/mTOR 
axis could synergize with calcineurin maintaining TFEB in 
a de-phosphorylated, and hence activated, form for longer 
time periods. An aspect that merits further investigation.
Another aspect of potential interest is represented by 
the positive control exerted by insulin and several growth 
factors on mTORC that should result in reduced ability 
to trigger autophagy and, possibly, reduced synergy to 
the calcineurin effects. Impaired insulin sensitivity, with 
increased insulin incretion, is a common phenomenon 
in aged people that can affect autophagy efficiency [37, 
38]. Accordingly, type 2 diabetes could find a right place 
in such a scenario. Actually, it has recently been shown 
that autophagy activation through positive control of 
transcription of key autophagy genes is decreased under 
conditions of insulin resistance [39].
In conclusion, our study provides evidence that 
the mechanism of autophagy activation by polyphenols 
resides on quite general effects of these substances 
on cell regulatory mechanisms underlying the control 
of autophagy. Our data add further knowledge to the 
molecular basis of OLE-induced autophagy that confirms 
and extends our previous studies carried out both in vivo 
and with a different cell line. When added to the available 
literature, our findings provide strong support to the idea 
that plant polyphenols are indeed useful to treat ageing and 
age-related diseases where autophagy dysfunction plays 
an important role such as cancer, neurodegeneration and 
type 2 diabetes thus reinforcing the theoretical basis for 
their use to combat these conditions.
MATERIALS AND METHODS
Oleuropein deglycosylation
Oleuropein (Extrasynthase) deglycosylation was 
performed as previously described [19]. Oleuropein 
aglycone was dissolved to 100 mM in DMSO to obtain 
a stock solution that was stored at -20 °C protected from 
light. Dilutions in aqueous buffers were made immediately 
before use.
Cell cultures
Human SH-SY5Y neuroblastoma cells and rat RIN-
5F insulinoma cells were from American Type Culture 
Collection (ATCC). SH-SY5Y cells were cultured in 
DMEM F-12/HAM (1:1) supplemented with 10% fetal 
calf serum (FCS, Sigma-Aldrich, Steinheim, Germany), 
glutamine and antibiotics. RIN-5F cells were cultured 
in RPMI medium supplemented with 10% FCS, 2.25 
g/L glucose, 10 mM HEPES, 1.0 mM, sodium pyruvate, 
glutamine and antibiotics. Both cell lines were maintained 
in a 5.0% CO2 humidified atmosphere at 37 °C.
Analysis of autophagic vacuoles
The Cyto-ID® Autophagy Detection Kit (Enzo 
Life Sciences) which uses a novel dye that selectively 
labels autophagic vacuoles in living cells was used to 
monitor autophagy induction by fluorescence microscopy, 
according to the manufacturer instructions. The cells were 
plated for 24 h in 24-well plates containing coverslips and 
then treated with 50 μM OLE for different time periods. 
In some experiments the cells were pre-treated for 30 min 
with 13.3 µM STO-609 (a CaMKKβ inhibitor), 4.0 mM 
EGTA (an impermeant Ca2+ chelator), 10 µM compound 
C (CC, an AMPK inhibitor) or for 1.0 h with 40 μM 
cyclopiazonic acid (CPA, an ER Ca2+-ATPase blocker 
(all inhibitors were from Sigma-Aldrich), before OLE 
administration. After incubation with OLE, the cells were 
washed and incubated for further 4.0 h in complete fresh 
medium. Then, the medium was removed and the cells 
were washed twice with 100 μl of PBS and then with 
100 μl of 1 × Assay-Buffer provided with Dectection 
Kit containing 10% FCS. After washing, the cells were 
incubated for 30 min at 37 °C with 100 μl of Dual detection 
reagent (prepared by diluting Cyto-ID Green Detection 
Reagent 330 times in a mixture of 1× Assay Buffer plus 
FCS), protected from light. Finally, the cells were washed 
three times with the same solution (1 × Assay Buffer-FCS 
10%) and the coverslips were placed on microscope slides. 
The stained cells were analyzed by using a confocal Leica 
TCS SP5 scanning microscope (Mannheim, Germany) 
equipped with an argon laser source for fluorescence 
measurements at 488 nm and a Leica Plan Apo 63 × oil 
immersion objective. A series of optical sections (1024 
× 1024 pixels) 1.0 μm in thickness was taken through 
the cell depth for each examined sample. The confocal 
microscope was set at optimal acquisition conditions, e.g., 
pinhole diameters, detector gain and laser powers. Settings 
were maintained constant for each analysis. Phase-contrast 
images were also acquired using the DIC channel. To 
quantify the green fluorescent signal, 10-22 cells were 
analyzed in each experiment using ImageJ software (NIH, 
Bethesda, MD). 
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Western blotting
In parallel with autophagic vacuoles analysis, OLE-
treated cells were analyzed by western blotting. To this 
purpose, the cells were lysed directly in Laemmli buffer 
(60 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 10 mM EDTA, 
10% (w/v) glycerol). Before immunoblotting, protein 
concentration was determined with a BCA detection 
kit (Pierce, USA) and adjusted to equal concentrations 
across different samples. The samples were added with 
β-mercaptoethanol and bromophenol blue, boiled for 10 
min, clarified at 10000 × g for 10 min, run on 12% SDS-
PAGE and transferred to PVDF membranes (Amersham 
Bioscience, UK). After blocking with 5.0% (w/v) BSA 
in 0.1% (v/v) PBS-Tween-20 or directly with methanol, 
the membranes were incubated overnight at 4 °C with 
specific primary antibodies: rabbit polyclonal anti-beclin1 
antibody (1:2000, Abcam), rabbit polyclonal anti-LC3II 
A/B antibody (1:1000, Cell Signaling), rabbit monoclonal 
anti-phospho-AMPKα (Thr172) and anti-AMPKα 
antibodies (1:1000, Cell Signaling). Mouse monoclonal 
anti-β−actin antibody (1:1000, Santa Cruz Biotechnology 
Inc.) was used for protein load normalization. The day 
after, the blots were incubated for 1.0 h with specific 
secondary antibodies (1:10000, goat anti-rabbit antibody 
and goat anti-mouse antibody, Molecular Probes, 
Life Technologies); the immunoreactive bands were 
detected with the Immobilon Western Chemiluminescent 
HRP substrate (Millipore) or SuperSignal West Pico 
chemiluminescent substrate (Thermo Fisher Scientific) 
and quantified by densitometric analysis using a 
ChemiDoc system and the Quantity One software (Bio-
Rad Laboratories, Italy). Statistical analysis of the bands 
was performed on results from at least three independent 
experiments, using ANOVA and Bonferroni’s post-test.
 Measurement of intracellular Ca2+ levels
The cytosolic levels of free Ca2+ were measured by 
using the Fluo-3-acetoxymethyl ester (Fluo-3AM) probe 
(Molecular Probes) whose fluorescence largely increases 
in response to Ca2+ binding. Subconfluent SH-SY5Y cells 
grown on glass coverslips were treated with 50 µM OLE 
for different time periods. At the end of each treatment, 
the cells were washed with PBS and incubated for 30 
min at 37 °C with 10 µM Fluo-3AM plus Pluronic F-127 
(20% in DMSO) at a 1:1 (v/v) ratio (the final DMSO 
concentration used to dissolve the probe was 0.04%). 
Then the cells were washed again and fixed in 2.0 % 
buffered paraformaldehyde for 20 min. Cell fluorescence 
was analyzed by confocal microscopy, quantified and 
statistically analyzed as described for autophagic vacuoles 
analysis.
Animal experiments
Transgenic (Tg) hemizygous CRND8 mice 
harboring a double-mutant gene of APP695 [40] and 
wild type (wt) control littermates were used following the 
ECC (DL 116/92, Directive 86/609/EEC) and National 
guidelines for animal care. The protocol was approved by 
the Committee on the Ethics of Animal Experiments of the 
Italian Ministry of Health (Permit Number: 283/2012-B). 
Tg and wt mice of 4 and 10 months of age at the beginning 
of treatment were used, n = 6 group/genotype, equally 
divided for sex. The animals were treated for 8 weeks with 
a modified low-fat (5.0%) AIN-76A diet (10 g/day per 
mouse) supplemented with OLE (50 mg/kg of diet) (OLE-
fed mice) or not (untreated mice) as previously reported 
[21, 23]. Tissue processing, immunohistochemistry and 
western blotting were also as previously reported [21, 23]. 
In western blotting, 1:1000 rabbit anti-phospho-p70 S6 
Kinase (Thr389), anti-phospho-AMPK (Thr172) and anti-
AMPK (Cell Signaling, MA, USA) antibodies were used; 
anti-actin rabbit antibody (Sigma Aldrich, MO, USA) was 
diluted 1:4000. In immunohistochemistry experiments, a 
rabbit anti-phospho-mTOR (S2448) polyclonal antibody 
(Abcam, Cambridge, UK) was used at 1:100 dilution.
Statistical analysis
One-way ANOVA, plus Bonferroni’s post-hoc 
test, was used to analyse Western blotting experiments. 
Statistical analyses were carried out with GraphPad Prism 
version 5.0 for Windows (San Diego, CA, USA) and the 
statistical significance was defined as p < 0.05. Data are 
reported as mean values ± standard error of the mean 
(S.E.M).
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